Regulatory T cells and intestinal homeostasis

Immunological Reviews

Volumn 204, Issue , 2005, Pages 184-194

  Coombes, Janine L ^a   Robinson, Nicholas J ^a   Maloy, Kevin J ^a   Uhlig, Holm H ^a,b   Powrie, Fiona ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL POPULATION; CELL PROLIFERATION; COLITIS; COMMENSALISM; CONTROLLED STUDY; DENDRITIC CELL; ENTERITIS; EPITHELIUM CELL; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; INTESTINE MUCOSA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CYTOKINES; HOMEOSTASIS; HUMANS; INFLAMMATORY BOWEL DISEASES; LYMPHOID TISSUE; T-LYMPHOCYTES;

EID: 16244379546     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2005.00250.x     Document Type: Review

References (84)

1. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-533.
2. Ogura Y, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-606.
3. Hugot JP, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
4. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999;11:648-656.
5. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993;5:1461-1471.
6. + T cells. J Exp Med 1993;178:237-244.
7. + T cells. Am J Pathol 1996;148:1503-1515.
8. + T cells. Immunity 1994;1:553-562.
9. Simpson SJ, et al. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med 1998;187:1225-1234.
10. + T-cells in the regulation of inflammatory responses in the intestine. Res Immunol 1997;148:576-581.
11. +, CD45RBhigh T cells to SCID recipients. J Immunol 1997;158:3464-3473.
12. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol 1997;148:567-576.
13. Schaedler RW, Dubos R, Costello R. The development of die bacterial flora in the gastrointestinal tract of mice. J Exp Med 1965;122:59-66.
14. Dubos R, Schaedler RW, Costello R, Hoet P. Indigenous, normal, and autochthonous flora of the gastrointestinal tract. J Exp Med 1965;122:67-76.
15. Salzman NH, de Jong H, Paterson Y, Harmsen HJ, Welling GW, Bos NA. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 2002;148:3651-3660.
16. Dewhirst FE, et al. Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol 1999;65:3287-3292.
17. Kullberg MC, et al. Helicobacter hepaticus triggers colitis in spedfic-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 1998;66:5157-5166.
18. Kuliberg MC, et al. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation. Infect Immun 2001;69:4232-4241.
19. Cahill RJ, Foltz CJ, Fox JG, Dangler CA, Powrie F, Schauer DB. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 1997;65:3126-3131.
20. Kullberg MC, et al. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 2002;196:505-515.
21. Li X, Fox JG, Whary MT, Yan L, Shames B, Zhao Z. SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis. Infect Immun 1998;66:5477-5484.
22. Ward JM, et al. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab Anim Sci 1996;46:15-20.
23. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003;197:111-119.
24. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
25. + regulatory T cells and IL-10. J Immunol 2003;171:971-978.
26. Malmstrom V, et al. Cd134l expression on dendritic cells in the mesenteric lymph nodes drives colitis in t cell-restored scid mice. J Immunol 2001;166:6972-6981.
27. Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse G. Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997;159:3838-3848.
28. Brocker T, Gulbranson-Judge A, Flynn S, Riedinger M, Raykundalia C, Lane P. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur J Immunol 1999;29:1610-1616.
29. De Jong YP, et al. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD 154 administration. Gastroenterology 2000;119:715-723.
30. + T cells by blocking the CD40-CD154 interactions. J Immunol 2000;164:6005-6014.
31. + T cell-mediated suppression by dendritic cells. Science 2003;299:677-682.
32. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
33. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-562.
34. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2:816-822.
35. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002;420:502-507.
36. + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001;2:301-306.
37. McHugh RS, et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-323.
38. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3:135-142.
39. Takahashi T, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192:303-310.
40. + regulatory T cells. Nat Immunol 2003;4:330-336.
41. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FOXP3. Science 2003;299:1057-1061.
42. + T regulatory cells. Nat Immunol 2003;4:337-342.
43. Ramsdell F, Ziegler SF. Transcription factors in autoimmunity. Curr Opin Immunol 2003;15:718-724.
44. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 2001;166:3008-3018.
45. + regulatory T cells. J Immunol 2003;170:3939-3943.
46. Geboes K, Dalle I. Influence of treatment on morphological features of mucosal inflammation. Gut 2002;50:11137-12.
47. + regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J Immunol 2003;171:5012-5017.
48. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
49. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
50. Gorelik L, Flavell RA. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2002;2:46-53.
51. Gorelik L, Flavell RA. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000;12:171-181.
52. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886.
53. + regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 2004;172:6003-6010.
54. Shull MM, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699.
55. Kulkarni AB, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90:770-774.
56. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell 1993;75:263-274.
57. Steidler L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000;289:1352-1355.
58. + T cell numbers. J Immunol 2002;169:4850-4860.
59. Takeda K, et al. Enhanced Thl activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10:39-49.
60. + T cells. J Exp Med 1996;183:2669-2674.
61. Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J Clin Invest 2001;108:601-609.
62. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001;194:629-644.
63. Piccirillo CA, et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta 1 production and responsiveness. J Exp Med 2002;196:237-246.
64. + regulatory T cell activity in both humans and mice. J Immunol 2004;172:834-842.
65. +CD45RBhigh- induced colitis by a TGF-beta-dependent mechanism. J Immunol 2003;170:2516-2522.
66. + Immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
67. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-1980.
68. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 2002;3:33-41.
69. + regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003;198:235-247.
70. Klein L, Khazaie K, von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 2003;100:8886-8891.
71. + regulatory T cells in vivo. J Exp Med 2003;198:249-258.
72. + regulatory T cells in the steady state. J Exp Med 2003;198:737-746.
73. + regulatory T cells. J Immunol 2003;171:5678-5682.
74. Gleeson PA, Toh BH, van Driel IR. Organ-specific autoimmunity induced by lymphopenia. Immunol Rev 1996;149:97-125.
75. Theofilopoulos AN, Dummer W, Kono DH. T cell homeostasis and systemic autoimmunity. J Clin Invest 2001;108:335-340.
76. King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004;117:265-277.
77. Stockinger G, Barthlott T, Kassiotis G. T cell regulation: a special job or everyone's responsibility? Nat Immunol 2001;2:757-758.
78. Barthlott T, Kassiotis G, Stockinger B. T cell regulation as a side effect of homeostasis and competition. J Exp Med 2003;197:451-460.
79. Jameson SC. Maintaining the norm: T-cell homeostasis. Nat Rev Immunol 2002;2:547-556.
80. + T cell pools. Eur J Immunol 1995;25:2127-2136.
81. Tanchot C, Rocha B. Peripheral selection of T cell repertoires: the role of continuous thymus output. J Exp Med 1997;186:1099-1106.
82. + T cells in the control of inflammation. J Immunol 2003;171:5018-5026.
83. +CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 2004;173:3119-3130.
84. + regulatory T cells. J Exp Med 2005; in press.